| Product Name | MF | CAS | Details |
|---|
| Flezurafenibum | C26H21FN4O3 | 2760321-00-2 | Details |
| Mesoporphyrin IX dihydrochloride | C34H39ClN4O4 | 68938-72-7 | Details |
| Tetrahydro Aldosterone | C21H32O5 | 13489-75-3 | Details |
| PPM1A-IN-1 | C16H15FNO2.Br | 2919466-30-9 | Details |
| HIV-1 inhibitor-64 | 2919019-36-4 | Details |
| GSK-3 inhibitor 6 | C21H17FN4O2 | 1772823-37-6 | Details |
| CDK7-IN-29 | C21H21N5OS | 3024545-83-0 | Details |
| SalA-VS-07 | C22H25ClN4O2 | 2445895-33-8 | Details |
| Rhodady C10 | C17H22N2O2S2 | 1367579-04-1 | Details |
| AhR agonist 8 | C17H15FN4O | 3036895-67-4 | Details |
| Ca(Ⅱ)-EDTA disodium dihydrate | C10H16CaN2Na2O10 | 6766-87-6 | Details |
| Lead Ionophore IV | C60H84N4O4S4 | 145237-46-3 | Details |
| NAD Synthetase | 9032-69-3 | Details |
| 8-CPT-cAMP-AM | C19H19ClN5O8PS | 663941-66-0 | Details |
| DACN(Tos) hydrochloride | C14H19ClN2O2S | 2331322-18-8 | Details |
| Biotin-C2-S-S-pyridine | C17H24N4O2S3 | 112247-65-1 | Details |
| 7-O-Demethyl rapamycin | C50H77NO13 | 151519-50-5 | Details |
| 2-Allyl-p-cresol | C10H12O | 6628-06-4 | Details |
| Thalidomide-methylpyrrolidine | 2616540-84-0 | Details |
| DHX9-IN-14 | C18H16F2N4O3S | 2973747-90-7 | Details |
| AKT-IN-22 | C33H26FN7O2 | 1313880-28-2 | Details |
| TMEM175 modulator 1 | C19H22F3N5O3 | 3038770-25-8 | Details |
| SMARCA2/4-IN-1 | C11H9ClN4O | 76947-79-0 | Details |
| CDD-1653 | C21H22N6O4S | 3034216-44-6 | Details |
| LY2023-001 | C19H18N6O3 | 327031-30-1 | Details |
| GPX4 activator 2 | C20H26N6O2S | 950365-31-8 | Details |
| G9a-IN-2 | C30H42N4O4 | 2648853-26-1 | Details |
| Anticancer agent 235 | C17H13ClN2O | 2411108-21-7 | Details |
| FM-1088 | C17H12F5NOS | 2410561-64-5 | Details |
| PDHK-IN-7 | C20H17F3N2O2 | 1220965-73-0 | Details |
| PROTAC SMARCA2 degrader-16 | C41H47N11O4 | 2568276-37-7 | Details |
| PROTAC SMARCA2 degrader-18 | 2408393-47-3 | Details |
| cGAMP | C20H24N10O13P2 | 849214-04-6 | Details |
| Bromofos | C8H8BrCl2O3PS | 2104-96-3 | Details |
| 7-CH-dADP | C11H16N4O9P2 | 187478-96-2 | Details |
| Edonentan hydrate | C28H34N4O6S | 264609-13-4 | Details |
| METTL3-IN-8 | C12H12N4O4 | 932512-38-4 | Details |
| PI3K/AKT-IN-3 | C44H63N5O7 | 2488891-30-9 | Details |
| Monoamine Oxidase B inhibitor 5 | C16H14FN3O2 | 2969160-15-2 | Details |
| HS-345 | C19H18N6O2S | 1462329-41-4 | Details |
| 5-LOX/MAOs-IN-1 | 33865-93-9 | Details |
| PROTAC c-Met degrader-1 | C45H41FN10O5 | 3056647-52-7 | Details |
| PF-04701475 | C17H24FN3O3S | 1488407-52-8 | Details |
| SC 44914 | C19H20N4O | 115812-74-3 | Details |
| JS11 | C23H28N4O3 | 1394592-04-1 | Details |
| CPK20 | C23H24F6N2O2S | 2397708-22-2 | Details |
| hVEGF-IN-3 | C14H13NO | 46739-60-0 | Details |
| PROTAC SMARCA2 degrader-27 | 2410314-57-5 | Details |
| Pyrocatechol sulfate | C6H6O5S | 4918-96-1 | Details |
| N-Nitroso nebivolol | C22H24F2N2O5 | 1391051-68-5 | Details |
| N-Acetyl-4-S-cysteaminylphenol | C10H13NO2S | 91281-32-2 | Details |
| N3-L-Dab(Boc)-OH | 1932403-71-8 | Details |
| CYP1B1 ligand 3 | C18H12ClN3S2 | 65823-65-6 | Details |
| Antibiotic adjuvant 1 | C16H10ClNO3 | 2351883-15-1 | Details |
| JJC8-088 dioxalate | 2068692-71-5 | Details |
| 2-Chloro-ATP | C10H15ClN5O13P3 | 49564-60-5 | Details |
| COB-187 | C15H14N2OS2 | 1862177-86-3 | Details |
| AW01178 | C19H21F3N4O2 | 651293-70-8 | Details |
| ON044580 | C23H15BrFNO5S | 1035199-04-2 | Details |
| MRS5663 | C22H21ClN6O3 | 1377272-66-6 | Details |
| Methyl (E)-oct-2-enoate | C9H16O2 | 7367-81-9 | Details |
| H-L-Tyr(2-azidoethyl)-OH | C11H14N4O3 | 1570523-47-5 | Details |
| 6-MB-cAMP | C14H18N5O7P.Na | 70253-67-7 | Details |
| HIV-1 integrase inhibitor 11 | C8H8N4OS | 54030-51-2 | Details |
| 4-Pentynoyl-Val-Ala-PAB | C20H27N3O4 | 1956294-75-9 | Details |
| GC373 | C21H29N3O5 | 1429218-54-1 | Details |
| HEI3090 | C18H15Cl3N4O3 | 2377167-56-9 | Details |
| LSN3074753 | C24H30FN5O2 | 1455031-68-1 | Details |
| Iditol | C6H14O6 | 488-45-9 | Details |
| AHL modulator-1 | C12H12BrNO3 | 942296-18-6 | Details |
| Tetrahydrouridine | C9H16N2O6 | 18771-50-1 | Details |
| Myristic amide | C14H29NO | 638-58-4 | Details |
| Sp-cCMPS | C9H12N3O6PS | 87063-81-8 | Details |
| Fluocinolone | C21H26F2O6 | 807-38-5 | Details |
| Boc-L-Aza-OH CHA | C14H27N5O4 | 2098496-88-7 | Details |
| SLCB050 | C21H18O6 | 1848971-16-3 | Details |
| HPO-DAEE | C12H22O4 | 1895934-61-8 | Details |
| MCHR1 antagonist 4 | C26H30N2O4 | 1574538-43-4 | Details |
| Cyprocide-B | C10H9ClN2OS | 49809-25-8 | Details |
| VK-2019 | C29H25NO4 | 2044520-06-9 | Details |
| Claziprotamidum | C19H20ClFN4O | 2361124-03-8 | Details |
| 6-Aminopyridine-3-thioamide | C6H7N3S | 53268-33-0 | Details |
| WHN-88 | C18H13I2N3O2 | 2490686-86-5 | Details |
| Sabialimon P | C31H50O4 | 2267333-96-8 | Details |
| Cernuumolide J | C24H34O8 | 2019163-02-9 | Details |
| PROTAC SMARCA2/4-degrader-33 | C44H51N11O4 | 2568276-36-6 | Details |
| CP-352664 | C18H18N4 | 1097883-05-0 | Details |
| H-(Gly)3-Lys(N3)-OH | C12H21N7O5 | 2250437-45-5 | Details |
| CARM1-IN-6 | C23H29N5O | 1269199-96-3 | Details |
| EP3 antagonist 7 | 740850-59-3 | Details |
| NLRP3-IN-43 | C25H31N5OS | 2769903-01-5 | Details |
| IP2015 | C17H19NO4 | 1320346-14-2 | Details |
| Caspase-3 activator 4 | C31H27N5O3 | 1817874-62-6 | Details |
| Taltobulin intermediate-4 | C22H40N2O5 | 187345-37-5 | Details |
| 8-Mercaptoguanosine | C10H13N5O5S | 26001-38-7 | Details |
| Pentyl dodecanoate | C17H34O2 | 5350-03-8 | Details |
| TAM558 intermediate-5 | C41H65N5O7S | 1415659-15-2 | Details |
| DACN(Tos,Suc-OH) | C18H22N2O5S | 2109751-68-8 | Details |
| RMC-113 | C21H15N3O2S | 2258606-34-5 | Details |
| Sp-8-Br-cAMPS | C10H11BrN5O5PS | 127634-20-2 | Details |
| Product Total： Product Page： | ||||
| 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 | ||||